⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →

Lasa Supergenerics Limited (LASA) — Insider Trading | 2 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

Promoter Omkar Herlekar disclosed no new share encumbrances for Lasa Supergenerics during FY2026, reaffirming compliance with SEBI takeover norms after previously disclosed holdings.

📄 View Original Announcement (PDF)

⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →
📊 Stock Analysis — LASA ✨ Ask AI About This

About Lasa Supergenerics Limited (LASA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹31.41 Cr ROE: -20.2% ROCE: -17.9%

View full LASA stock details →

📡 Get AI alerts when LASA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LASA — Free

💡 Ask AI about this filing

Ask AI Free →

📊 More LASA filings

See all LASA filings →

🔥 Also filed on 2 June 2026

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LASA files new disclosures

Track LASA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LASA — Free

Free account · 2 AI queries/day

⚡ StockFin Pro Go Pro — bigger Radar, no daily limits Upgrade

© 2026 StockFin.ai — AI-powered Indian stock research

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd